Annual Working Capital
$459.84 M
+$62.02 M+15.59%
December 31, 2023
Summary
- As of February 21, 2025, VRDN annual working capital is $459.84 million, with the most recent change of +$62.02 million (+15.59%) on December 31, 2023.
- During the last 3 years, VRDN annual working capital has risen by +$340.91 million (+286.63%).
- VRDN annual working capital is now at all-time high.
Performance
VRDN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$725.99 M
+$181.09 M+33.23%
September 30, 2024
Summary
- As of February 21, 2025, VRDN quarterly working capital is $725.99 million, with the most recent change of +$181.09 million (+33.23%) on September 30, 2024.
- Over the past year, VRDN quarterly working capital has increased by +$425.40 million (+141.52%).
- VRDN quarterly working capital is now at all-time high.
Performance
VRDN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
VRDN Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +15.6% | +141.5% |
| 3 y3 years | +286.6% | +141.5% |
| 5 y5 years | +684.2% | +141.5% |
VRDN Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +146.5% | at high | +401.5% |
| 5 y | 5-year | at high | +2251.1% | at high | +3611.8% |
| alltime | all time | at high | +1921.5% | at high | +2975.7% |
Viridian Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $725.99 M(+33.2%) |
| Jun 2024 | - | $544.90 M(-9.3%) |
| Mar 2024 | - | $600.69 M(+30.6%) |
| Dec 2023 | $459.84 M(+15.6%) | $459.84 M(+53.0%) |
| Sep 2023 | - | $300.59 M(-5.4%) |
| Jun 2023 | - | $317.67 M(-10.0%) |
| Mar 2023 | - | $353.01 M(-11.3%) |
| Dec 2022 | $397.82 M(+113.3%) | $397.82 M(-3.5%) |
| Sep 2022 | - | $412.14 M(+184.7%) |
| Jun 2022 | - | $144.76 M(-12.3%) |
| Mar 2022 | - | $165.00 M(-11.5%) |
| Dec 2021 | $186.53 M(+56.8%) | $186.53 M(-8.4%) |
| Sep 2021 | - | $203.60 M(+106.4%) |
| Jun 2021 | - | $98.63 M(-6.2%) |
| Mar 2021 | - | $105.10 M(-11.6%) |
| Dec 2020 | $118.94 M(+508.1%) | $118.94 M(+387.2%) |
| Sep 2020 | - | $24.41 M(-5.4%) |
| Jun 2020 | - | $25.80 M(-13.1%) |
| Mar 2020 | - | $29.68 M(+51.7%) |
| Dec 2019 | $19.56 M | $19.56 M(-29.7%) |
| Sep 2019 | - | $27.83 M(-28.5%) |
| Jun 2019 | - | $38.93 M(-17.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $47.35 M(-19.3%) |
| Dec 2018 | $58.64 M(+22.2%) | $58.64 M(-14.9%) |
| Sep 2018 | - | $68.92 M(-10.4%) |
| Jun 2018 | - | $76.94 M(-6.4%) |
| Mar 2018 | - | $82.22 M(+71.4%) |
| Dec 2017 | $47.97 M(<-9900.0%) | $47.97 M(+20.3%) |
| Sep 2017 | - | $39.89 M(-6.6%) |
| Jun 2017 | - | $42.72 M(-14.0%) |
| Mar 2017 | - | $49.66 M(<-9900.0%) |
| Dec 2016 | -$326.00 K(-103.5%) | -$326.00 K(-108.9%) |
| Sep 2016 | - | $3.66 M(-31.8%) |
| Jun 2016 | - | $5.37 M(-25.7%) |
| Mar 2016 | - | $7.23 M(-22.0%) |
| Dec 2015 | $9.27 M(+93.2%) | $9.27 M(-19.4%) |
| Sep 2015 | - | $11.49 M(+17.4%) |
| Jun 2015 | - | $9.78 M(-18.4%) |
| Mar 2015 | - | $12.00 M(+150.1%) |
| Dec 2014 | $4.80 M(-119.0%) | $4.80 M(-28.0%) |
| Sep 2014 | - | $6.66 M(-12.7%) |
| Jun 2014 | - | $7.63 M(-6061.5%) |
| Mar 2014 | - | -$128.00 K(-99.5%) |
| Dec 2013 | -$25.25 M(+15.1%) | -$25.25 M |
| Dec 2012 | -$21.94 M | - |
FAQ
- What is Viridian Therapeutics annual working capital?
- What is the all time high annual working capital for Viridian Therapeutics?
- What is Viridian Therapeutics annual working capital year-on-year change?
- What is Viridian Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly working capital year-on-year change?
What is Viridian Therapeutics annual working capital?
The current annual working capital of VRDN is $459.84 M
What is the all time high annual working capital for Viridian Therapeutics?
Viridian Therapeutics all-time high annual working capital is $459.84 M
What is Viridian Therapeutics annual working capital year-on-year change?
Over the past year, VRDN annual working capital has changed by +$62.02 M (+15.59%)
What is Viridian Therapeutics quarterly working capital?
The current quarterly working capital of VRDN is $725.99 M
What is the all time high quarterly working capital for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly working capital is $725.99 M
What is Viridian Therapeutics quarterly working capital year-on-year change?
Over the past year, VRDN quarterly working capital has changed by +$425.40 M (+141.52%)